Mitochondrial control of fuel switching via carnitine biosynthesis.
Summary
This mechanistic study identifies SLC25A45 as the mitochondrial trimethyllysine carrier required for carnitine biosynthesis, thereby enabling mitochondrial fatty acid oxidation and fuel switching. Loss of SLC25A45 depletes carnitine and impairs fatty acid oxidation, shifting metabolism toward carbohydrate usage.
Key Findings
- SLC25A45 was identified as the mitochondrial carrier for trimethyllysine, enabling carnitine biosynthesis.
- SLC25A45 deficiency reduced the cellular carnitine pool and impaired mitochondrial fatty acid oxidation.
- Metabolic fuel use shifted toward carbohydrates when SLC25A45 was deficient.
Clinical Implications
Modulating SLC25A45-carnitine pathways could inform strategies for metabolic disorders, carnitine deficiency, and dietary adaptations (e.g., plant-based diets) where fatty acid oxidation capacity is critical.
Why It Matters
Revealing a previously unrecognized mitochondrial carrier that governs carnitine biosynthesis provides a fundamental advance in metabolic flexibility and nutrient adaptation biology.
Limitations
- Preclinical mechanistic work; human genetic/clinical validation is needed
- Quantitative physiological impacts across tissues and dietary contexts require further study
Future Directions
Validate SLC25A45 variants in humans; assess therapeutic modulation of carnitine biosynthesis in metabolic disease and in dietary adaptation states.
Study Information
- Study Type
- Basic/Mechanistic research
- Research Domain
- Pathophysiology
- Evidence Level
- V - Preclinical mechanistic evidence without direct clinical outcomes
- Study Design
- OTHER